Candriam S.C.A. lifted its stake in Maximus, Inc. (NYSE:MMS – Free Report) by 16.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 92,725 shares of the health services provider’s stock after buying an additional 13,376 shares during the period. Candriam S.C.A.’s holdings in Maximus were worth $5,944,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. QRG Capital Management Inc. grew its holdings in shares of Maximus by 9.3% during the first quarter. QRG Capital Management Inc. now owns 3,240 shares of the health services provider’s stock worth $208,000 after buying an additional 277 shares during the last quarter. Counterpoint Mutual Funds LLC purchased a new position in Maximus in the first quarter worth $4,195,000. Y Intercept Hong Kong Ltd boosted its position in shares of Maximus by 198.8% during the 1st quarter. Y Intercept Hong Kong Ltd now owns 69,073 shares of the health services provider’s stock worth $4,428,000 after purchasing an additional 45,953 shares in the last quarter. Elevation Point Wealth Partners LLC purchased a new position in Maximus in the first quarter valued at about $219,000. Finally, 1492 Capital Management LLC increased its stake in Maximus by 62.4% in the 1st quarter. 1492 Capital Management LLC now owns 6,131 shares of the health services provider’s stock valued at $393,000 after purchasing an additional 2,355 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.
Analyst Ratings Changes
MMS has been the subject of several research reports. Weiss Ratings downgraded Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Wall Street Zen raised shares of Maximus from a “hold” rating to a “buy” rating in a research note on Saturday, June 6th. Finally, Zacks Research lowered Maximus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 27th. Two investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, Maximus presently has a consensus rating of “Hold”.
Maximus Trading Up 2.9%
NYSE:MMS opened at $58.28 on Tuesday. The company has a market cap of $3.06 billion, a PE ratio of 8.72 and a beta of 0.60. The business’s 50 day moving average is $59.37 and its two-hundred day moving average is $71.50. The company has a quick ratio of 2.21, a current ratio of 2.21 and a debt-to-equity ratio of 0.87. Maximus, Inc. has a 52 week low of $52.73 and a 52 week high of $100.00.
Maximus (NYSE:MMS – Get Free Report) last issued its earnings results on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, topping the consensus estimate of $1.98 by $0.09. The firm had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.32 billion. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The firm’s revenue for the quarter was down 4.1% on a year-over-year basis. During the same period last year, the company earned $2.01 earnings per share. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. On average, analysts predict that Maximus, Inc. will post 8.43 EPS for the current year.
Maximus Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Investors of record on Friday, August 14th will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.32 dividend on an annualized basis and a yield of 2.3%. Maximus’s dividend payout ratio (DPR) is presently 19.76%.
Maximus Company Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Read More
- Five stocks we like better than Maximus
- The SK Hynix IPO and 2027’s AI Memory Squeeze
- Meta Platforms Stock Rises as Muse Spark 1.1 AI Model Debuts
- Why Welltower’s Growth Story Might Outrun Its Rich Valuation
- One Short- and One Long-Term ETF for Quantum Computing Bulls
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
